Photodynamic therapy: Basic and preclinical aspects

CRC Handbook of: Organic Photochemistry and Photobiology, Second Edition

Volumn , Issue , 2003, Pages 146-1-146-10

  Jori, Giulio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35348989314     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (49)

1. Dougherty, T.J., Gomer, C.J., Henderson, B.W., Jori, G., Kessel, D., Korbelik, M., Moan, J., and Peng, Q., Photodynamic therapy: a review, J. Natl. Cancer Inst., 90, 889, 1998.
2. Boyle, R.W. and David, D., Structure and biodistribution relationships of photodynamic sensitizers, Photochem. Photobiol., 64, 469, 1996.
3. Levy, J.G. and Obochi, M., New applications in photodynamic therapy, Photochem. Photobiol., 64, 737, 1996.
4. Allen, C.M., Sharman, W.M., and van Lier, J.E., Current status of phthalocyanines in the photodynamic therapy of cancer, J. Porphyrins Phthalocyanines, 5, 161, 2001.
5. Schmidt-Erfurth, U. and Hasan, T., Mechanisms of action of photodynamic therapy with Verteporfin for the treatment of age-related macular degeneration, Survey Ophthalmol., 45, 195, 2000.
6. Anderson, R.R. and Parrish, J.A., Optical properties of human skin, in The Science of Photomedicine, Regan, J.D. and Parrish, J.A., Eds., Plenum Press, New York, 1982, p. 174.
7. Brancaleon, L. and Moseley, H., Laser and non-laser light sources for photodynamic therapy, Lasers Med. Sci., 17, 173, 2002.
8. Krishnadath, K.K., Feyes, D.K., Boothman, D., Mukhtar, H., and Sano, K., Persistent genetic abnormalities in Barrett’s oesophagus after photodynamic therapy, Gastroenterology, 119, 624, 2000.
9. Jori, G., Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy, J. Photochem. Photobiol., B: Biol., 36, 87, 1996.
10. Sounik, J.R., Schechtman, L.A., Rihter, B.D., Ford, W.E., Rodgers, M.A.J., and Kenney, M.E., Synthesis and characterization of naphthalocyanines and phthalocyanines of use in sensitizer studies, in Photodynamic The rapy: Mechanisms II, Vol. 1203, Dougherty, T.J. and Katzir, A., Eds., SPIE, Bellingham, 1990, p. 224.
11. Reddi, E. and Jori, G., Steady-state and time-resolved spectroscopic studies of photodynamic sensitizers: porphyrins and phthalocyanines, Rev. Chem. Interm., 10, 241, 1998.
12. Soncin, M., Busetti, A., Biolo, R., Jori, G., Kwag, G., Li, Y.-S., Kenney, M.E., and Rodgers, M.A.J., Photoinactivation of amelanotic and melanotic melanoma cells sensitized by axially substituted Si-naphthalocyanines, J. Photochem. Photobiol., B: Biol., 42, 202, 1998.
13. Dougherty, T.J., Photodynamic therapy, Photochem. Photobiol., 58, 895, 1993.
14. Nonell, S. and Redmond, R.W., On the determination of quantum yields for singlet molecular oxygen photosensitization, J. Photochem. Photobiol., B: Biol., 22, 171, 1994.
15. Oleinick, N.L. and Evans, H.H., The photobiology of photodynamic therapy: cellular targets and mechanisms, Radiat. Res., 150, 146, 1998.
16. Girotti, A.W., Photosensitized oxidation of cholesterol in biological systems: reaction pathways, cytotoxic effects and defense mechanisms, J. Photochem. Photobiol., B: Biol., 13, 105, 1992.
17. Spikes, J.D., Photobiology of porphyrins, in Porphyrin Localization and Treatment of Tumours, Doiron, D.R. and Gomer, C.J., Eds., Alan R. Liss, New York, 1994, p. 19.
18. Jori, G. and Spikes, J.D., Photobiochemistry of porphyrins, in Topics in Photomedicine, Smith, K.C., Ed., Plenum Press, New York, 1983, p. 183.
19. Jori, G., Molecular and cellular mechanisms in photomedicine, in Primary Photoprocesses in Medicine and Biology, Plenum Press, New York, 1985, p. 349.
20. Spikes, J.D., Quantum yield and kinetics of the photobleaching of haematoporphyrin, Photofrin II, tetra(4-sulfonatophenyl)porphine and uroporphyrin, Photochem. Photobiol., 55, 797, 1992.
21. Henderson, B.W. and Dougherty, T.J., How does photodynamic therapy work?, Photochem. Photobiol., 55, 145, 1992.
22. Jori, G. and Reddi, E., Second generation photosensitizers for the photodynamic therapy of tumours, in Light in Biology and Medicine, Vol. 2, Douglas, R.H., Moan, J., and Ronto G., Eds., Plenum Press, New York, 1991, p. 253.
23. Kessel, D., Subcellular localization of photosensitizing agents, Photochem. Photobiol., 65, 387, 1997.
24. Berg, K., Mechanisms of cell damage in photodynamic therapy, in The Fundamental Basis of Phototherapy, Honigsmann, H., Jori, G., and Young, A.R., Eds., OEMF, Milan, 1996, p. 181.
25. Evans, S., Matthews, W., Perry, R., Fraker, D., Norton, J., and Pass, H.I., Effect of photodynamic therapy on tumour necrosis factor production by murine macrophages, J. Natl. Cancer Inst., 82, 34, 1990.
26. Gomer, C.J., Luna, M., Ferrario, A., Wong, S., Fischer, A., and Rucker, N., Cellular targets and molecular responses associated with photodynamic therapy, J. Clin. Laser Med. Surg., 14, 315, 1996.
27. Oleinick, N.L., Morris, R.L., and Belichencko, I., The role of apoptosis in response to photodynamic therapy: what, where, why and how, Photochem. Photobiol. Sci., 1, 1, 2002.
28. Agarwal, M.L., Larkin, H.E., Zaidi, S.I., Antunez, A.R., and Oleinick, N.L., Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells, Cancer Res., 51, 5993, 1991.
29. Fabris, C., Valduga, G., Miotto, G., Borsetto, L., Jori, G., Garbisa, S., and Reddi, E., Photosensitization with Zn(II)-phthalocyanine as a switch in the decision between apoptosis and necrosis, Cancer Res., 61, 7495, 2001.
30. Kessel, D. and Luo, Y., Photodynamic therapy: a mitochondrial inducer of apoptosis, Cell Death Differ., 6, 28, 1999.
31. Dellinger, M., Apoptosis or necrosis following Photofrin photosensitization: influence of the incubation protocol, J. Photochem. Photobiol., B: Biol., 39, 19, 1997.
32. Ochsner, M., Photophysical and photobiological processes in the photodynamic therapy of tumours, J. Photochem. Photobiol., B: Biol., 39, 1, 1997.
33. Ruck, A. and Diddens, H., Uptake and subcellular distribution of photosensitizing drugs in malignant cells, in The Fundamental Bases of Phototherapy, Honigsmann, H., Jori, G., and Young, A.R., Eds., OEMF, Milan, 1996, p. 209.
34. Jori, G. and Reddi, E., The role of lipoproteins in the delivery of tumour-targeting photosensitizers, Int. J. Biochem., 25, 1369, 1993.
35. Allison, B.A., Warefield, E., Richter, A.M., and Levy, J.G., The effects of plasma lipoproteins on in vitro tumour cell killing and in vivo tumour photosensitization with benzoporphyrin derivative, Photochem. Photobiol., 54, 709, 1991.
36. Kongshaug, M., Distribution of tetrapyrrole photosensitizers among human plasma proteins, Int. J. Biochem., 24, 1239, 1992.
37. Fingar, V.H., Vascular effects of photodynamic therapy, J. Clin. Laser Surg. Med., 14, 323, 1996.
38. Fingar, V.H., Kik, P.K., Haydon, P.S., Cerrito, P.B., Tseng, M., Abang, E., and Wieman, T.J., Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative, Br. J. Cancer, 79, 1702, 1999.
39. Korbelik, M., Induction of tumour immunity by photodynamic therapy, J. Clin. Laser Surg. Med., 14, 329, 1996.
40. Canti, G., Lattuada, D., Nicolin, A., Taroni, A., Valentini, G., and Cubeddu, A., Antitumour immunity induced by photodynamic therapy with aluminum phthalocyanine and laser light, Anticancer Drugs, 5, 443, 1994.
41. Canti, G., De Simone, A., and Korbelik, M., Photodynamic therapy and the immune response system in experimental oncology, Photochem. Photobiol. Sci., 1, 79, 2002.
42. Korbelik, M. and Krosl, G., Enhanced macrophage cytotoxicity against tumour cells treated with photodynamic therapy, Photochem. Photobiol., 60, 497, 1994.
43. Hsi, R.A., Rosenthal, D.I., and Glatstein, E., Photodynamic therapy in the treatment of cancer, current state of the art, Drug, 57, 725, 1999.
44. Pass, H.I., Photodynamic therapy in oncology: mechanisms and clinical use, J. Natl. Cancer Inst., 85, 443, 1993.
45. Ochsner, M., Photodynamic therapy: the clinical perspective. Review of applications for the control of diverse tumorous and non-tumorous diseases, Arzneim. Forsch., 47, 1185, 1997.
46. Busetti, A., Soncin, M., Jori, G., and Rodgers, M.A.J., Treatment of malignant melanoma by highpeak-power 1064 nm irradiation followed by photodynamic therapy, Br. J. Cancer, 79, 821, 1999.
47. Jori, G. and Spikes, J.D., Photothermal sensitizers: possible use in tumour therapy, J. Photochem. Photobiol., B: Biol., 6, 93, 1990.
48. Busetti, A., Soncin, M., Reddi, E., Rodgers, M.A.J., Kenney, M.E., and Jori, G., Photothermal sensitization of amelanotic melanoma cells by Ni(II)-octabutoxy-naphthalocyanine, J. Photochem. Photobiol., B: Biol., 53, 103, 1999.
49. Soncin, M., Busetti, A., Fusi, F., Jori, G., and Rodgers, M.A.J., Irradiation of amelanotic and melanotic melanoma cells with 532 nm high peak power pulsed laser radiation in the presence of the photothermal sensitizer Cu(II)-haematoporphyrin: a new approach to cell photoinactivation, Photochem. Photobiol., 69, 708, 1999.